Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients

European Journal of Surgical Oncology

Volumn 32, Issue 2, 2006, Pages 224-227

  Knorr, Christian ^a   Meyer, T ^a   Janssen, T ^a   Goehl, J ^a   Hohenberger, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Complications; Isolated limb perfusion; Malignant melanoma; Recurrence; Response

Indexed keywords

DACTINOMYCIN; MELPHALAN;

ADULT; AGED; ANEMIA; ARTICLE; BLISTER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL PROTOCOL; COMPARTMENT SYNDROME; DEATH; FASCIOTOMY; FEMALE; FISTULA; HUMAN; HYPERTHERMIC THERAPY; KNEE AMPUTATION; LEUKOPENIA; LIMB PERFUSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MULTIPLE ORGAN FAILURE; PERIPHERAL PARALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURVIVAL RATE; THROMBOCYTOPENIA; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DACTINOMYCIN; EXTREMITIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MELANOMA; MELPHALAN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 32944473866     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2005.09.007     Document Type: Article

References (15)

1. O.J. Creech Jr E.T. Krementz R.F. Ryan J.N. Winbald Chemtherapy of cancer: Regional perfusion utilizing an extracorporal circuit Ann Surg 148 1958 616-632
2. W. Hohenberger Isolation perfusion for malignant melanomas: Established facts and parameters to be clarified R. Jakesz H. Rainer Progress in regional cancer therapy 1990 Springer Berlin 182
3. T. Meyer J. Göhl C. Haas W. Hohenberger Hyperthermic isolated limb perfusion - 23 years' experience and improvement of results by modification of technique Onkologie 21 1998 198-202
4. J.L. Smith Histopathology and biological behaviour of melanoma J.L. Smith Neoplasms of skin and malignant melanoma 1976 Year Book Medical Publishers Chicago 293
5. J. Wieberdink C. Benckhuijsen R.P. Braat E.A. van Slooten G.A. Olthuis Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions Eur J Cancer Clin Oncol 18 1982 905-910
6. D. Lienard A.M. Eggermont B.R. Kroon H.S. Koops F.J. Lejeune Isolated Limb perfusion in primary and recurrent melanoma: Indications and results Semin Surg Oncol 14 1998 202-209
7. D. Lienard F.J. Lejune P. Ewalenko In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion World J Surg 16 1992 234-240
8. M. Vaglini F. Belli M. Ammatuna MG. Inglese R. Manzi A. Prada Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon and melphalan Cancer 73 1994 483-492
9. F. Di Filippo F. Cavaliere R. Garinei M. Anza P. Di Angelo A. Psalia TNFα-based isolated hyperthermic limb perfusion (HILP) in the treatment of limb recurerent melanoma: Update 16 years after its first clinical application J Chemother 16 Suppl 5 2004 62-65
10. C.R. Rossi M. Foletto P. Pilati S. Mocellin M. Lise Isolated limb perfusion in locally advanced cutaneous melanoma Semin Oncol 29 2002 400-409
11. J.F. Thompson J.A. Hunt K.F. Shannon P.C. Kam Frequency and duration of remission after isolated limb perfusion for melanoma Arch Surg 132 8 1997 903-907
12. E.T. Krementz C.M. Sutherland J.H. Muchmore Isolated hyperthermia chemotherapy perfusion for limb melanoma Surg Clin North Am 76 1996 1313-1330
13. F. DiFilipo A. Calabro D. Giannarelli S. Carlini F. Cavaliere F. Moscarelli Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion Cancer 63 1989 2551-2561
14. T. Meyer S. Merkel J. Goehl W. Hohenberger Surgical therapy for distant metastases of malignant melanoma Cancer 89 2000 1983-1991
15. H.S. Koops M. Vaglini S. Suciu BB. Kroon JF. Thompson J. Gohl Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593 J Clin Oncol 16 1998 2906-2912